Specifically, isoform-specific alterations of Akt, the serine-threonine kinase whose 3 isoforms are encoded by distinct genes and frequently overexpressed in numerous cancers, were recently found to have divergent effects in ovarian cancer cells and the nearby microenvironment (Linnerth-Petrik et al., 2016). The gene discussed is MARK2; the disease is ovarian cancer.